Novartis Ag earnings were $12.9B for the trailing 12 months ending Mar 31, 2025, with -12.6% growth year over year. The latest NVS earnings report on Mar 31, 2025 announced Q1 2025 earnings of $3.6B, up 28% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVS reported annual earnings of $11.9B, with -19.6% growth. The next NVS earnings date is Jul 17, 2025.
NVS past earnings growth
How has NVS's earnings growth performed historically?
On NVS's earnings call on Invalid Date, Novartis Ag (NYSE: NVS) reported Q1 2025 earnings per share (EPS) of $1.83, up 39.69% year over year. Total NVS earnings for the quarter were $3.61 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $1.31.
The next NVS earnings call is Invalid Date. Add NVS to your watchlist to be reminded of Novartis Ag's next earnings date.
What was NVS's earnings growth in the past year?
As of Novartis Ag's earnings date in Invalid Date, Novartis Ag's earnings has grown -12.62% year over year. This is 124.23 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 111.61%. NVS earnings in the past year totalled $12.86 billion.
Is Novartis Ag profitable or losing money?
As of the last Novartis Ag earnings report, Novartis Ag is currently profitable. Novartis Ag's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $12.86 billion, a 15.65% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.